Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
Add more filters










Publication year range
1.
Eur J Nutr ; 59(4): 1463-1472, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31119400

ABSTRACT

PURPOSE: Aim of this study was to identify a possible relationship among dietary fatty acids (FA) intake, FA adipose tissue (AT) profile and cancer condition in lean vs obese subjects affected or not by colorectal cancer (CRC). Actually, inadequate dietary habits together with physical inactivity are primary determinants of obesity and cancer risk. Changes in lipid metabolism play a crucial role in different types of cancer and key enzymes involved in lipid-metabolic pathways, such as stearoyl-coA-desaturase 1 (SCD-1), are differentially expressed in normal and cancer tissues. METHODS: Food frequency questionnaires (FFQ) were analyzed by Winfood software. FA were assessed by gas-liquid chromatography in visceral AT samples. Estimated desaturase activities were calculated as precursor FA/product FA ratio. Desaturase gene expressions were evaluated by RT-qPCR. RESULTS: Lean and obese CRC subjects showed inadequate dietary habits. In particular, lean CRC subjects showed increase in the intake of saturated FA, specifically palmitic (p = 0.0042) and stearic acid (p = 0.0091), and a corresponding reduction of monounsaturated FA consumption, in particular oleic acid (p = 0.002) with respect to lean without CRC. Estimated SCD-1 activity in AT was increased in all the groups vs lean without CRC (pANOVA = 0.029). CONCLUSIONS: Unhealthy eating habits, characterizing obese and CRC subjects, may influence the visceral AT profile and contribute to the alteration of the metabolic pathways. The quality of the diet, other than the quantity, can have a main role in the establishment of inflammatory microenvironment and in metabolic changes favouring CRC.


Subject(s)
Colorectal Neoplasms/blood , Diet/adverse effects , Diet/methods , Fatty Acids/blood , Intra-Abdominal Fat/metabolism , Obesity/blood , Adult , Aged , Female , Humans , Male , Middle Aged
3.
Blood ; 98(10): 2909-16, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11698270

ABSTRACT

Human immunodeficiency virus type 1 (HIV-1) uses the chemokine receptors CCR5 and CXCR4 as coreceptors for entry. It was recently demonstrated that HIV-1 glycoprotein 120 (gp120) elevated calcium and activated several ionic signaling responses in primary human macrophages, which are important targets for HIV-1 in vivo. This study shows that chemokine receptor engagement by both CCR5-dependent (R5) and CXCR4-dependent (X4) gp120 led to rapid phosphorylation of the focal adhesion-related tyrosine kinase Pyk2 in macrophages. Pyk2 phosphorylation was also induced by macrophage inflammatory protein-1beta (MIP-1beta) and stromal cell-derived factor-1alpha, chemokine ligands for CCR5 and CXCR4. Activation was blocked by EGTA and by a potent blocker of calcium release-activated Ca++ (CRAC) channels, but was insensitive to pertussis toxin (PTX), implicating CRAC-mediated extracellular Ca++ influx but not Galpha(i) protein-dependent mechanisms. Coreceptor engagement by gp120 and chemokines also activated 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase/stress-activated protein kinase and p38 MAPK. Furthermore, gp120-stimulated macrophages secreted the chemokines monocyte chemotactic protein-1 and MIP-1beta in a manner that was dependent on MAPK activation. Thus, the gp120 signaling cascade in macrophages includes coreceptor binding, PTX-insensitive signal transduction, ionic signaling including Ca++ influx, and activation of Pyk2 and MAPK pathways, and leads to secretion of inflammatory mediators. HIV-1 Env signaling through these pathways may contribute to dysregulation of uninfected macrophage functions, new target cell recruitment, or modulation of macrophage infection.


Subject(s)
Calcium Signaling/physiology , HIV Envelope Protein gp120/physiology , MAP Kinase Signaling System/physiology , Macrophages/virology , Mitogen-Activated Protein Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , Receptors, CCR5/physiology , Receptors, CXCR4/physiology , Calcium/physiology , Calcium Channel Blockers/pharmacology , Calcium Signaling/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Chelating Agents/pharmacology , Chemokine CCL2/metabolism , Chemokine CCL4 , Egtazic Acid/pharmacology , Enzyme Activation/drug effects , Focal Adhesion Kinase 2 , HIV Envelope Protein gp120/pharmacology , Humans , JNK Mitogen-Activated Protein Kinases , MAP Kinase Signaling System/drug effects , Macrophage Activation/drug effects , Macrophage Inflammatory Proteins/metabolism , Macrophages/metabolism , Monocytes/drug effects , Pertussis Toxin , Phosphorylation , Protein Processing, Post-Translational , Receptors, CCR5/drug effects , Receptors, CXCR4/drug effects , Recombinant Proteins/pharmacology , Virulence Factors, Bordetella/pharmacology , p38 Mitogen-Activated Protein Kinases
4.
J Immunol ; 166(9): 5381-7, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11313374

ABSTRACT

The present study was designed to evaluate the effect of the HIV-1 envelope glycoprotein gp120 on the expression of beta-chemokines in cultured monocytes/macrophages. Treatment of either freshly isolated 1-day-cultured monocytes or 7-day-cultured monocyte-derived macrophages (MDM) with recombinant gp120-IIIB resulted in a specific and dose-dependent enhancement of secretion of monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and RANTES as well as a clear-cut increase in transcript accumulation. The expression of these mRNA was increased, but not superinduced, in the presence of cycloheximide. beta-Chemokine secretion was also induced after exposure of monocyte cultures to gp120-JRFL and aldrithiol-2-inactivated R5 and X4 HIV-1 strains, retaining conformational and functional integrity of envelope proteins. In contrast, no beta-chemokine secretion was triggered by X4 and R5 gp120 or aldrithiol-2-inactivated virus treatment of monocytoid cell lines that were fully responsive to LPS. The gp120-mediated effect was independent of its interaction with CD4, as preincubation with soluble CD4 did not abrogate beta-chemokine induction. Moreover, triggering of CD4 receptor by a specific Ab did not result in any beta-chemokine secretion. Interestingly, engagement of CCR5 and CXCR4 receptors by specific Abs as well as treatment with CCR5 and CXCR4 ligands induced beta-chemokine secretion. On the whole, these results indicate that HIV-1 stimulates monocytes/macrophages to produce beta-chemokines by a specific interaction of gp120 with HIV-1 coreceptors on the cell membrane. The expression of these related polypeptides may represent an important cellular response for regulating both the extent of viral infection and the recruitment of immune cells.


Subject(s)
CD4 Antigens/physiology , Chemokines, CC/biosynthesis , HIV Envelope Protein gp120/pharmacology , HIV-1/immunology , Monocytes/immunology , Monocytes/virology , Adolescent , Adult , Antigens, Viral/pharmacology , Cell Line , Cells, Cultured , Chemokine CCL2/biosynthesis , Chemokine CCL2/genetics , Chemokine CCL4 , Chemokine CCL5/biosynthesis , Chemokine CCL5/genetics , Chemokines, CC/blood , Chemokines, CC/metabolism , Humans , Lipopolysaccharides/pharmacology , Macrophage Inflammatory Proteins/biosynthesis , Macrophage Inflammatory Proteins/genetics , Male , Monocytes/metabolism , RNA, Messenger/biosynthesis , Receptors, Chemokine/physiology , Species Specificity , Transcription, Genetic/immunology , U937 Cells , Up-Regulation/immunology
5.
J Biol Chem ; 276(1): 355-63, 2001 Jan 05.
Article in English | MEDLINE | ID: mdl-11035028

ABSTRACT

Infection of host cells by viruses leads to the activation of multiple signaling pathways, resulting in the expression of host genes involved in the establishment of the antiviral state. Among the transcription factors mediating the immediate response to virus is interferon regulatory factor-3 (IRF-3) which is post-translationally modified as a result of virus infection. Phosphorylation of latent cytoplasmic IRF-3 on serine and threonine residues in the C-terminal region leads to dimerization, cytoplasmic to nuclear translocation, association with the p300/CBP coactivator, and stimulation of DNA binding and transcriptional activities. We now demonstrate that IRF-3 is a phosphoprotein that is uniquely activated via virus-dependent C-terminal phosphorylation. Paramyxoviridae including measles virus and rhabdoviridae, vesicular stomatitis virus, are potent inducers of a unique virus-activated kinase activity. In contrast, stress inducers, growth factors, DNA-damaging agents, and cytokines do not induce C-terminal IRF-3 phosphorylation, translocation or transactivation, but rather activate a MAPKKK-related signaling pathway that results in N-terminal IRF-3 phosphorylation. The failure of numerous well characterized pharmacological inhibitors to abrogate virus-induced IRF-3 phosphorylation suggests the involvement of a novel kinase activity in IRF-3 regulation by viruses.


Subject(s)
DNA-Binding Proteins/metabolism , Protein Kinases/metabolism , Signal Transduction , Transcription Factors/metabolism , Virus Physiological Phenomena , Active Transport, Cell Nucleus/drug effects , DNA Damage/drug effects , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Enzyme Inhibitors/pharmacology , Genes, Reporter , Growth Substances/pharmacology , Humans , Interferon Regulatory Factor-3 , Jurkat Cells , MAP Kinase Kinase Kinases/metabolism , MAP Kinase Signaling System/drug effects , Models, Biological , Mutagenesis , NF-kappa B/metabolism , Oxidative Stress , Phosphoproteins/chemistry , Phosphoproteins/genetics , Phosphoproteins/metabolism , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Phosphoric Monoester Hydrolases/metabolism , Phosphorylation/drug effects , Protein Kinase Inhibitors , Protein Structure, Tertiary , Respirovirus/physiology , Signal Transduction/drug effects , Transcription Factors/chemistry , Transcription Factors/genetics , Transcriptional Activation/drug effects
6.
Eur Cytokine Netw ; 12(4): 597-603, 2001.
Article in English | MEDLINE | ID: mdl-11781186

ABSTRACT

We investigated the effect of IFN-beta on beta-chemokine expression in differentiating human peripheral blood monocytes. MCP-1, MIP-1alpha and MIP-1beta were constitutively expressed in 1 day-cultured monocytes, and their secretion increased with time in culture despite any change in mRNA accumulation. IFN-beta treatment of differentiating monocytes resulted in a marked and dose-dependent increase of beta-chemokine secretion, which was regulated differently with respect to the differentiation stage. In particular, IFN-beta upregulated MCP-1 secretion in monocytes at all stages of differentiation although its effect was significantly higher in 1-day cultured monocytes as compared to monocyte-derived macrophages (MDM). In contrast, MIP-1alpha and MIP-1beta secretion was up-regulated by IFN-beta only in MDM. Although MCP-1, MIP-1alpha and MIP-1beta mRNA expression was up-regulated by IFN-beta in both 1 day-cultured monocytes and MDM, no correlation was found between mRNA level and protein secretion. These results suggest that the regulation of beta-chemokine secretion in monocytes/macrophages by IFN-beta occurred through different mechanisms, involving both a direct effect of this cytokine on chemokine gene expression and translational/post-translational steps of regulation more likely linked to the differentiation process. This finding reveals a novel role for this cytokine in the recruitment of specific cell types during the immune response, which may be relevant in the control of viral infections in vivo.


Subject(s)
Cell Differentiation/physiology , Chemokines, CC/biosynthesis , Interferon-beta/physiology , Macrophages/cytology , Monocytes/metabolism , Adolescent , Adult , Chemokines, CC/genetics , Humans , In Vitro Techniques , Male , RNA, Messenger/genetics
7.
J Leukoc Biol ; 68(5): 707-14, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11073111

ABSTRACT

We characterized the IL-12 response of mouse macrophages in terms of modulation of IFN-gamma production by cytokines (IFN-alpha and IL-18) and regulation of IL-12 receptor expression. Beta1 and beta2 IL-12R chain mRNA expression increased with time in culture in the absence of exogenous stimulation, with concomitant acquisition of responsiveness to IL-12 for IFN-gamma production. Expression of the IL-12R beta1 chain mRNA was increased further following IL-12 treatment as a consequence of IFN-gamma expression. IL-12 response was regulated differentially by IFN-alpha and IL-18. Neutralization of endogenous type I IFN increased IFN-gamma secretion, whereas exogenous IFN-alpha reduced it. In contrast, IL-18 enhanced IFN-gamma mRNA accumulation and IFN-gamma secretion in IL-12-stimulated, but not -untreated, cultures. The opposite effects exerted by IFN-alpha and IL-18 mirror their mutual capacity of regulating-in a negative or positive manner, respectively-the expression of the IL-12R beta1 chain. We suggest that differential regulation of IL-12 response by IFN-alpha and IL-18 can represent previously unrecognized regulatory mechanisms for maintaining suitable levels of differentiation/activation in macrophages.


Subject(s)
Interferon Type I/pharmacology , Interferon-gamma/biosynthesis , Interleukin-12/pharmacology , Interleukin-18/pharmacology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Receptors, Interleukin/biosynthesis , Animals , Cells, Cultured , Drug Synergism , Inflammation/immunology , Inflammation/pathology , Interferon Type I/biosynthesis , Interferon Type I/physiology , Interleukin-12/antagonists & inhibitors , Macrophages, Peritoneal/immunology , Male , Mice , Mice, Inbred C3H , Receptors, Interleukin-12 , Recombinant Proteins/pharmacology
8.
Virology ; 277(2): 270-7, 2000 Nov 25.
Article in English | MEDLINE | ID: mdl-11080475

ABSTRACT

We had previously reported that freshly harvested peritoneal macrophages (PM) are in a type I IFN-mediated antiviral state, which is lost during in vitro culture of PM, concomitantly with a progressive decline in the expression of IFN-beta. We report herein that in vitro culture of PM in the presence of IL-4 or IL-10 results in an enhanced decay of the IFN-beta-mediated antiviral state to vesicular stomatitis virus (VSV). Moreover, IL-4 and IL-10 inhibited the production of type I IFN induced by LPS or NDV infection, as assessed by IFN production and induction of IFN-mediated antiviral state. The accumulation and physiological turnover of IFN-beta mRNA was not affected by IL-4 or IL-10. Finally, neither IL-10 nor IL-4 exerted any inhibitory effect on the antiviral activity induced by exogenous type-I IFN. These results suggest that Th2 cytokines, such as IL-4 and IL-10, act as negative regulators of the type I IFN-mediated antiviral response in PM and may represent stop signals for the constitutive or induced type I IFN expression in PM.


Subject(s)
Interferon-beta/biosynthesis , Interleukin-10/pharmacology , Interleukin-4/pharmacology , Macrophages, Peritoneal/drug effects , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Down-Regulation , Interferon-beta/genetics , Lipopolysaccharides , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/virology , Male , Mice , Mice, Inbred C3H , Newcastle disease virus , RNA, Messenger/genetics , Specific Pathogen-Free Organisms , Time Factors , Vesicular stomatitis Indiana virus
9.
J Virol ; 74(21): 10207-11, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11024150

ABSTRACT

Jurkat T-cell clones, stably expressing the human immunodeficiency virus type 1 (HIV-1) Vpr protein, exhibited an impaired susceptibility to HIV-1 infection. A marked down-modulation of surface CD4 receptors was detected in Vpr-expressing clones with respect to control cells. Likewise, a reduced CD4 expression was also observed in parental Jurkat cells infected with wild-type but not with Vpr-mutant HIV-1. Notably, Vpr-expressing clones were fully susceptible to infection with a vesicular stomatitis virus G protein-pseudotyped HIV-1 virus, indicating that a block at the level of viral entry was responsible for the inhibition of viral replication. The effect exerted by Vpr on HIV replication and CD4 expression suggests that this protein can regulate both the establishment of a productive HIV-1 infection and CD4-mediated T-cell functions.


Subject(s)
CD4 Antigens/metabolism , Gene Products, vpr/metabolism , HIV-1/physiology , Down-Regulation , Gene Products, vpr/genetics , HIV-1/genetics , Humans , Jurkat Cells , Virus Replication , vpr Gene Products, Human Immunodeficiency Virus
10.
J Leukoc Biol ; 68(3): 391-9, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10985256

ABSTRACT

The monocyte/macrophage lineage represents heterogeneous cell populations characterized by major differences in the phenotype and functional activities. These cells are a major source of soluble factors, such as cytokines and chemokines, which can both affect HIV replication and AIDS pathogenesis. Although monocytes/macrophages are unanimously considered important targets of HIV-1 infection, the HIV-induced alterations in their physiological functions at different stages of differentiation are still matter of debate. In this article, we review our data on the regulation of chemokine/cytokine network with regard to macrophage differentiation and HIV-1 infection, in comparison with studies from other groups. The ensemble of the results emphasizes that: 1) macrophages markedly differ with respect to monocytes for a variety of responses potentially important in the pathogenesis of HIV infection; and 2) the experimental conditions can influence the HIVmonocyte/macrophage interactions, reflecting the possible in vivo existence of a spectrum of responses among macrophage populations.


Subject(s)
Chemokines/physiology , Cytokines/physiology , Macrophages/cytology , Macrophages/virology , Monocytes/cytology , Monocytes/virology , Cell Differentiation/physiology , Chemokines/biosynthesis , Cytokines/biosynthesis , HIV Infections , HIV-1/pathogenicity , Humans , Macrophages/metabolism , Monocytes/metabolism
11.
J Immunol ; 165(6): 3293-300, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-10975846

ABSTRACT

We investigated the effect of vpr, physiologically expressed during the course of an acute HIV-1 infection, on the response of infected cells to apoptotic stimuli as well as on the HIV-induced apoptosis. At 48 h after infection, Jurkat cells exhibited a lower susceptibility to undergo apoptosis with respect to uninfected cells. This effect was not observed following infection with either a vpr-mutated virus or a wild-type strain in the presence of antisense oligodeoxynucleotides targeted at vpr mRNA. Single-cell analysis, aimed at simultaneously identifying apoptotic and infected cells, revealed that resistance to apoptosis correlated with productive infection. Notably, vpr-dependent protection from induced apoptosis was also observed in HIV-1-infected PBMC. In contrast, at later stages of infection, a marked increase in the number of cells spontaneously undergoing apoptosis was detected in infected cultures. This virus-induced apoptosis involved vpr expression and predominantly occurred in productively infected cells. These results indicate that HIV-1 vpr can exert opposite roles in the regulation of apoptosis, which may depend on the level of its intracellular expression at different stages of HIV-1 infection. The dual function of vpr represents a novel mechanism in the complex strategy evolved by HIV to influence the turnover of T lymphocytes leading to either viral persistence or virus release and spreading.


Subject(s)
Apoptosis/immunology , Gene Products, vpr/physiology , HIV-1/physiology , T-Lymphocytes/cytology , T-Lymphocytes/virology , Acute Disease , Apoptosis/drug effects , Cycloheximide/pharmacology , Gene Products, vpr/antagonists & inhibitors , Gene Products, vpr/biosynthesis , Gene Products, vpr/genetics , HIV Infections/immunology , HIV Infections/pathology , HIV Infections/virology , Humans , In Situ Nick-End Labeling , Jurkat Cells/cytology , Jurkat Cells/drug effects , Jurkat Cells/immunology , Jurkat Cells/virology , Oligodeoxyribonucleotides, Antisense/pharmacology , Phenotype , RNA, Messenger/antagonists & inhibitors , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Tumor Necrosis Factor-alpha/pharmacology , Virus Latency/immunology , vpr Gene Products, Human Immunodeficiency Virus
12.
Cell Death Differ ; 7(1): 25-36, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10713718

ABSTRACT

We have previously shown that CD4+ T Jurkat cells constitutively expressing low levels of the human immunodeficiency virus 1 (HIV-1) vpr protein were less susceptible to undergo apoptosis than control cells.1 In this study we have investigated the role of vpr in affecting mechanisms of importance in the control of apoptosis. Vpr-expressing clones consistently aggregated in clusters with time in culture, whereas mock-transfected cells grew as dispersed cultures. The analysis of adhesion molecules involved in cell-to-cell as well as in cell-substrate interactions showed a higher expression of cadherin and integrins alpha5 and alpha6 in vpr-transfected clones with respect to mock-transfected cells. This up-modulation was specifically blocked by cell exposure to antisense oligonucleotides targeted at the vpr. In addition, F-actin microfilament cytoskeletal organization, known to be involved in cell-cell interaction pathways and in the modulation of cell surface molecule expression, was significantly improved in vpr-expressing clones, in which filament polymerization was increased. We thus envisage that vpr viral protein can maintain cell survival via a specific activity on cytoskeleton-dependent cell adhesion pathways, i.e. by inducing anoikis-resistance. These particular effects of vpr might enhance the homing, spreading and survival of the infected lymphocytes, thus contributing to virus persistence in the course of acute HIV-1 infection.


Subject(s)
Actin Cytoskeleton/physiology , Apoptosis , Cell Adhesion/physiology , Gene Products, vpr/metabolism , HIV-1/metabolism , Antigens, CD/metabolism , Cadherins/metabolism , Cell Division , Cytoplasm/metabolism , Cytoskeleton , Gene Expression , Gene Products, vpr/genetics , Homeostasis , Humans , Integrin alpha5 , Integrin alpha6 , Intracellular Membranes/metabolism , Intracellular Membranes/physiology , Jurkat Cells , Mitochondria/physiology , Proto-Oncogene Proteins c-bcl-2/metabolism , Transfection , vpr Gene Products, Human Immunodeficiency Virus
13.
Lab Invest ; 79(10): 1299-309, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10532592

ABSTRACT

P-glycoprotein (Pgp), the product of the multidrug resistance (MDR1) gene, is expressed in a variety of normal tissues but very little is known about its expression and function in cells of the immune system. In this study, we investigated the effect of interferon-gamma (IFN-gamma) on the expression and activity of Pgp in human peripheral blood monocyte-derived macrophages (MDM). We report that IFN-gamma up-regulated Pgp expression in a dose- and time-dependent manner. We show that IFN-gamma slightly increased the accumulation of MDR1 mRNA and induced a polarized redistribution of Pgp, as well as of some cytoskeletal proteins (ie, ezrin, actin, and alpha-actinin) on cell pseudopodia. Notably, confocal microscopy studies showed that Pgp and ezrin colocalized in these cellular structures. The IFN-gamma-induced Pgp up-modulation was a specific response of primary macrophages, as IFN-gamma treatment of primary lymphocytes and monocytic cell lines did not result in any increase of Pgp expression. Finally, IFN-gamma stimulated the Pgp transport activity in MDM, as rhodamine 123-efflux increased in treated cells as compared with control cultures. These results indicate that Pgp expression and activity can be up-regulated in human MDM in response to IFN-gamma. We suggest that IFN-gamma may be involved in the induction of multidrug resistance in macrophages.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/blood , Genes, MDR , Interferon-gamma/pharmacology , Macrophages/drug effects , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Cell Lineage , Cells, Cultured , Fluorescent Dyes , Humans , Macrophages/metabolism , Monocytes/drug effects , Monocytes/metabolism , Up-Regulation
14.
J Virol ; 73(9): 7328-33, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10438821

ABSTRACT

We investigated the role of the constitutive nitric oxide (NO) in the expression of interferon (IFN) genes in mouse peritoneal macrophages (PM). The treatment of PM with L-arginine-N(G)-amine (AA), a potent inhibitor of NO-producing enzymes, resulted in a marked accumulation of IFN-alpha4 mRNA and, to a minor extent, of IFN-beta mRNA. In contrast, the expression of IFN-gamma mRNA, as well as tumor necrosis factor alpha and interleukin-6 mRNA, was not affected. Furthermore, a remarkable increase in the expression of the IFN regulating factor 1 (IRF-1), but not of IRF-2, mRNA was detected in AA-treated PM. To investigate whether the AA-induced activation of the IFN system correlates with the production and antiviral activity of IFN, the extent of encephalomyocarditis virus (EMCV) replication was monitored in AA-treated PM with respect to control cultures. AA treatment strongly inhibited, in a dose-dependent manner, EMCV yields in PM. Likewise, similar results were obtained by the addition of the NO-scavenger carboxyphenyl-tetramethylimidazoline-oxyl-oxide. In addition, inhibition of NO synthesis by N(G)-mono-methyl-L-arginine in PM strongly decreased virus replication in coculture of PM and EMCV-infected L929 cells, whereas no antiviral effect was observed in L929 cells alone. Moreover, the AA-mediated antiviral activity was abrogated in the presence of antibody to IFN-alpha/beta, whereas antibody to IFN-gamma was completely ineffective. Taken together, these results indicate that low levels of NO, constitutively released by resting PM, negatively regulate the expression and activity of IFN-alpha/beta in PM. We suggest that NO acts as a homeostatic agent in the regulation of IFN pathway expression in macrophages.


Subject(s)
Interferon-alpha/genetics , Interferon-beta/genetics , Macrophages, Peritoneal/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/metabolism , Animals , Cell Line , Cells, Cultured , Coculture Techniques , Encephalomyocarditis virus/drug effects , Encephalomyocarditis virus/physiology , Enzyme Inhibitors/pharmacology , Female , Gene Expression Regulation/drug effects , Interferon-alpha/metabolism , Interferon-beta/metabolism , Interferon-gamma/genetics , Interleukin-6/genetics , Macrophages, Peritoneal/metabolism , Mice , Nitric Oxide Synthase Type II , Tumor Necrosis Factor-alpha/genetics , Virus Replication/drug effects , omega-N-Methylarginine/pharmacology
15.
Blood ; 94(3): 875-83, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10419877

ABSTRACT

Human peripheral blood monocytes differentiate into macrophages when cultured in vitro for a few days. In the present study, we investigated the expression of C-C chemokine and CXCR4 receptors in monocytes at different stages of differentiation. Culturing of monocytes for 7 days resulted in a progressive decrease of the mRNA that encodes for CCR2 and CCR3, whereas the expression of mRNA for other chemokine receptors (CCR1, CCR4, CCR5, and CXCR4) was not substantially affected. The loss of CCR2 mRNA expression in 7-day-cultured macrophages was associated with a strong reduction in the receptor expression at the plasma membrane, as well as in the monocyte chemotactic protein (MCP-1) binding, as compared with freshly isolated monocytes. Furthermore, the biologic response to MCP-1, as measured by intracellular calcium ions increase and chemotactic response, was lost in 7-day-cultured macrophages. Differentiation of monocytes into macrophages also resulted in an increased secretion of MCP-1 that, at least in part, was responsible for the downmodulation of its receptor (CCR2). The loss of CCR2 expression and the parallel increase of MCP-1 secretion triggered by differentiation may represent a feedback mechanism in the regulation of the chemotactic response of monocytes/macrophages.


Subject(s)
Chemokine CCL2/pharmacology , Chemotaxis/drug effects , Monocytes/cytology , Monocytes/metabolism , Receptors, Chemokine , Receptors, Cytokine/biosynthesis , Cell Differentiation/drug effects , Cells, Cultured , Humans , Monocytes/immunology , Receptors, CCR2 , Receptors, Cytokine/immunology , Signal Transduction
16.
J Infect Dis ; 179(4): 832-42, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10068578

ABSTRACT

Elevated levels of circulating tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 have been detected in human immunodeficiency virus (HIV) type 1 infection. The overproduction of these cytokines could contribute to AIDS pathogenesis. Thus, the expression of TNF-alpha and IL-6 in human macrophages infected with HIV-1 was investigated. HIV-1 infection, per se, did not induce any TNF-alpha or IL-6 production or cytokine-specific mRNA expression. In contrast, HIV-1 primed macrophages to a prolonged TNF-alpha and IL-6 response to lipopolysaccharide (LPS) stimulation with respect to uninfected cells. Time-course analysis and flow cytometry demonstrated that cytokine production stopped at 6 h in uninfected macrophages but continued up to 24 h in HIV-1-infected cells. RNA studies suggested that HIV-1 interfered with late steps of cytokine synthesis. No modulation of membrane CD14 was found to account for the enhanced response to LPS. Finally, the effect of HIV-1 on cytokine response could not be abolished by the antiviral compound U75875.


Subject(s)
HIV-1/physiology , Interleukin-6/biosynthesis , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Tumor Necrosis Factor-alpha/biosynthesis , Humans , Interleukin-6/genetics , Lipopolysaccharide Receptors/analysis , Macrophage Colony-Stimulating Factor/pharmacology , Macrophages/immunology , Macrophages/virology , Oligopeptides/pharmacology , RNA, Messenger/analysis , Tumor Necrosis Factor-alpha/genetics
17.
Int J Biochem Cell Biol ; 30(9): 1055-62, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9785469

ABSTRACT

Lactoferrin is a mammalian iron-binding glycoprotein present in many biological secretions, such as milk, tears, semen and plasma and a major component of the specific granules of polymorphonuclear leucocytes. The effect of bovine lactoferrin (BLf) in apo-form or saturated with ferric, manganese or zinc ions, on human immunodeficiency virus type 1 (HIV-1) infection in the C8166 T-cell line was studied. Both HIV-1 replication and syncytium formation were efficiently inhibited, in a dose-dependent manner, by lactoferrins. BLf in apo and saturated forms markedly inhibited HIV-1 replication when added prior to HIV infection or during the virus adsorption step, thus suggesting a mechanism of action on the HIV binding to or entry into C8166 cells. Likewise, the addition of Fe3+BLf prior to HIV infection and during the attachment step resulted in a marked reduction of the HIV-1 DNA in C8166 cells 20 h after infection. The potent antiviral effect and the high selectivity index exhibited by BLf suggest for this protein, in apo or saturated forms, an important role in inhibiting the early HIV-cell interaction, even though a post adsorption effect cannot be ruled out.


Subject(s)
Anti-HIV Agents/pharmacology , HIV-1/drug effects , Lactoferrin/pharmacology , Adsorption , Animals , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/chemistry , Apoproteins/administration & dosage , Apoproteins/chemistry , Apoproteins/pharmacology , Cattle , Cell Line , Cytopathogenic Effect, Viral/drug effects , DNA, Viral/metabolism , Dose-Response Relationship, Drug , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/pathogenicity , HIV-1/physiology , Humans , Lactoferrin/administration & dosage , Lactoferrin/chemistry , Metals/pharmacology , Virus Replication/drug effects
19.
Cytokine Growth Factor Rev ; 9(2): 117-23, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9754706

ABSTRACT

IFN-gamma is a pleiotropic cytokine endowed with potent immunomodulatory effects whose expression was long considered to be restricted to T and NK cells. Only recently, it became evident that IFN-gamma production can also occur in other cell types, including monocyte/macrophages. However, the biological relevance of macrophage IFN-gamma is still unclear. The purpose of this article is to provide an overview of the collected evidence demonstrating IFN-gamma expression in macrophages and to discuss the possible biological significance of this cytokine production in the early phase of host response to infectious agents.


Subject(s)
Interferon-gamma/physiology , Macrophages/immunology , Animals , Cytokines/physiology , Gene Expression Regulation , Humans , Infections/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Mice , Models, Biological
20.
Hum Gene Ther ; 9(5): 621-8, 1998 Mar 20.
Article in English | MEDLINE | ID: mdl-9551610

ABSTRACT

Human immunodeficiency virus (HIV) infection represents one of the most challenging systems for gene therapy. Thanks to the extended knowledge of the molecular biology of the HIV life cycle, many different strategies have been developed including transdominant modifications of HIV proteins, RNA decoys, antisense RNA, ribozymes, and intracellular antibody fragments. In this paper, we have tested in a human T lymphoblastoid cell line the antiviral activity of ribozymes specifically designed to co-localize inside the nucleus with the Rev pre-mRNA before it is spliced and transported to the cytoplasm. This result was obtained by inserting the ribozyme in the spliceosomal U1 small nuclear RNA (snRNA) and in a derivative that has perfect complementarity with the 5' splice site of the Rev pre-mRNA. These ribozymes were tested in human T cell clones and were shown to be very efficient in inhibiting viral replication. Not only were the p24 levels in the culture medium drastically reduced but so were the intracellular HIV transcripts. Control disabled ribozymes enabled us to show the specificity of the ribozyme activity. Therefore, these constructs have potential utility for gene therapy of HIV-1 infection.


Subject(s)
Anti-HIV Agents/pharmacology , HIV-1/drug effects , HIV-1/physiology , RNA, Catalytic/genetics , RNA, Catalytic/pharmacology , Virus Replication/drug effects , Chimera , Gene Dosage , Genetic Therapy , Humans , Jurkat Cells , RNA , RNA Precursors/metabolism , RNA, Small Nuclear , RNA, Viral/analysis , RNA, Viral/metabolism , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...